# US 10,369,276 B2 · Accurately delivering partial doses of a drug post dilution using an injector > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 10,369,276 B2 - Document ID: US10369276B2 - Status: Granted - Kind: B2 - Application number: 15/037,515 - Filed: 2014-11-25 - Published: 2016-09-29 - Granted: 2019-08-06 - Earliest claimed: 2013-11-25 - Assignees: Bayer HealthCare LLC - Applicants: Bayer Healthcare LLC - Inventors: Arthur E. Uber, III - Web page: https://patentgrep.com/patent/US10369276B2 ## CPC - A61M 5/14546: {Front-loading type injectors} - A61M 5/16827: {controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths (infusion of multiple fluids without using a controller A61M5/1407)} - A61M 5/007: {for contrast media} - A61M 5/1411: {Drip chambers (A61M5/1689, A61M5/40 take precedence)} - A61M 5/142: Pressure infusion, e.g. using pumps - A61M 5/178: Syringes - A61M 5/20: Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically (A61M5/142 takes precedence) - A61M 2005/14292: {Computer-based infusion planning or simulation of spatio-temporal infusate distribution} - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} ## Abstract Methods and systems for diluting a dose of a substance to be delivered to a patient and for determining a maximum deliverable dose of the substance and/or a partial fluid volume to be delivered to the patient to provide a desired dose amount are provided. The method includes the step of providing a first substance within a fluid reservoir having an initial unit value. The method also includes diluting the first substance with a second substance to produce the diluted solution. Once the first substance is diluted, a total volume (VTotal) of the diluted solution is measured. A concentration of the diluted solution is then calculated based on the initial unit value and the total volume (VTotal). A fluid delivery system including a fluid reservoir and fluid delivery device, which is configured to perform the method, is also provided. ## Claims ### Claim 1 A method of determining a maximum deliverable dose or a non-deliverable dose in a fluid reservoir, the method comprising: providing a first substance within the fluid reservoir having an initial dose value; diluting the first substance with a second substance to produce a diluted solution; determining a total volume (VTotal) of the diluted solution; calculating the maximum deliverable dose or the non-deliverable dose within the reservoir based on the initial dose value and at least two of a deliverable volume (VDeliverable), a non-deliverable volume (VNon-deliverable), a concentration of the diluted solution, a total dose, and the total volume (VTotal) wherein the fluid reservoir is selected from the group consisting of a syringe barrel, a cartridge, a medical vial, an intravenous bag, a sample container, a length of tubing, and a pump reservoir. ### Claim 2 (depends on 1) The method of claim 1, wherein the initial dose value is selected from the group consisting of a mass or number of molecules of the first substance, a radioactivity of the first substance, a number of live cells present in the first substance, and a number of units of biological activity of the first substance. ### Claim 3 (depends on 1) The method of claim 1, further comprising calculating a current dose value based on the initial dose value, an elapsed time and a decay rate, or on an estimated lifespan of living cells of the first substance, wherein the decay rate is based on a half-life of a radioactive component of the first substance. ### Claim 4 (depends on 1) The method of claim 1, wherein the total volume (VTotal) is an initially unknown value and determinable based on a fluid level in a fluid path element. ### Claim 5 (depends on 4) The method of claim 4, further comprising automatically determining the fluid level based on data provided by one or more sensors. ### Claim 6 (depends on 5) The method of claim 5, wherein the one or more sensors comprise one or more sensors selected from the group consisting of an optical sensor, a pressure sensor, an ultrasonic sensor, a radio sensor, and any combination thereof. ### Claim 7 A method for determining a maximum deliverable dose within a reservoir, the method comprising: providing a first substance within the reservoir having an initial dose value; introducing a second substance to the reservoir to produce a diluted solution; determining a total volume (VTotal), wherein the total volume is the sum of a volume of the first substance and a volume of the second substance; calculating the maximum deliverable dose within the reservoir based on the initial dose value and a ratio of a deliverable volume (VDeliverable) and the total volume (VTotal), and delivering up to the maximum deliverable dose to a patient through a fluid delivery system, wherein the fluid delivery system comprises the reservoir and a fluid path element in fluid communication with the reservoir and configured for delivering fluid from the reservoir to the patient. ### Claim 8 (depends on 7) The method of claim 7, wherein the deliverable volume (VDeliverable) is equal to the total volume (VTotal) less a non-deliverable volume (VNon-deliverable). ### Claim 9 (depends on 8) The method of claim 8, wherein the non-deliverable volume (VNon-deliverable) is measured by filling at least part of one or more fluid path elements connected to the reservoir with fluid from the reservoir and then measuring a remaining volume in the reservoir. ### Claim 10 (depends on 8) The method of claim 8, wherein the non-deliverable volume (VNon-deliverable) is a known quantity based on shapes of the reservoir and one or more fluid path elements connected to the reservoir. ### Claim 11 (depends on 10) The method claim 10, wherein the non-deliverable volume (VNon-deliverable) is defined by at least a portion of the fluid path element or the reservoir. ### Claim 12 (depends on 7) The method of claim 7, further comprising calculating a dose volume (VDose) based on a desired actual dose value of the first substance, the initial dose value, and the total volume (VTotal). ### Claim 13 (depends on 12) The method of claim 12, further comprising confirming that the dose volume (VDose) is less than or equal to the deliverable volume (VDeliverable) of the reservoir. ### Claim 14 A fluid delivery system comprising: a fluid reservoir configured for receiving a first substance having an initial dose value; a fluid conduit configured for introducing a second substance into the fluid reservoir to produce a diluted solution; a fluid delivery device having a fluid delivery conduit configured for delivering at least a portion of the diluted solution from the fluid reservoir to a patient; and a controller configured to determine a maximum deliverable dose capable of being delivered to the patient or non-deliverable dose that remains in the fluid reservoir, wherein the controller calculates the maximum deliverable dose or non-deliverable dose based on the initial dose value and at least two of a deliverable volume (VDeliverable), a non-deliverable volume (VNon-deliverable), a concentration of the diluted solution, a total dose, and a total volume (VTotal). ### Claim 15 (depends on 14) The system of claim 14, further comprising at least one sensor configured to provide information used to determine the total volume (VTotal) based on a fluid level in a fluid path element, wherein the at least one sensor is selected from the group consisting of an optical sensor, a pressure sensor, an ultrasonic sensor, a radio sensor, an optical sensor, a conductivity sensor, a fluid sensor, and any combination thereof. ### Claim 16 (depends on 15) The system of claim 15, wherein the at least one sensor is positioned to measure a position of a meniscus of the fluid solution contained within the fluid reservoir after priming of the fluid reservoir and the fluid conduit by the fluid delivery device. ### Claim 17 (depends on 14) The system of claim 14, wherein the fluid delivery device is selected from the group consisting of a hand injector, a power injector, an auto-injector, a gravity based drip mechanism, a pneumatic pump, a peristaltic pump, and an infusion pump. ### Claim 18 (depends on 14) The system of claim 14, wherein the controller comprises at least one non-transitory computer-readable storage medium in communication with one or more processors and having instructions stored thereon, which, when executed by the one or more processors, causes the one or more processors to: determine the total volume (VTotal) of the first substance and the second substance based on data received from the one or more sensors; and calculate the maximum deliverable dose within the fluid reservoir based on a current dose value and a ratio of the deliverable volume (VDeliverable) and the total volume (VTotal). ### Claim 19 (depends on 18) The system of claim 18, wherein the controller further causes the one or more processors to: calculate the current dose value based on the initial dose value, elapsed time data obtained from a timer, and a decay rate. ### Claim 20 (depends on 14) The system of claim 14, wherein the controller is further configured to actuate the fluid delivery device to deliver a partial dose of the diluted solution to the patient, the partial dose being less than or equal to the maximum deliverable dose.